BILLERICA, Mass., Feb. 25, 2019 /PRNewswire/ -- Bruker
Corporation (Nasdaq: BRKR) announced today it will present at the
following conferences:
8th Annual SVB Leerink Healthcare Conference,
New York, NY
Thursday, February 28, 2019, at
10:30 a.m. Eastern Time
Frank Laukien, Chairman, President
and Chief Executive Officer
Cowen 39th Annual Health Care Conference,
Boston, MA
Tuesday, March 12, 2019, at
10:40 a.m. Eastern Time
Gerald Herman, Chief Financial
Officer
Barclays Global Healthcare Conference, Miami Beach, FL
Thursday, March 14, 2019, at
10:45 a.m. Eastern Time
Frank Laukien, Chairman, President
and Chief Executive Officer
Live audio webcasts of the presentations will be available on
the Investor Relations section of the Company's website at
https://ir.bruker.com. Replays will be posted on the Bruker
Corporation Investor Relations website after each event and will be
available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker's high-performance scientific instruments and
high-value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, clinical phenomics
and proteomics research and clinical microbiology. For more
information, please visit: www.bruker.com.
Contact:
Miroslava
Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
E: Miroslava.Minkova@Bruker.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-investor-conferences-300801492.html
SOURCE Bruker Corporation